Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction

Cohn, 1984, Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure, N Engl J Med, 311, 819, 10.1056/NEJM198409273111303 Packer, 1988, Neurohumoral interactions and adaptations in congestive heart failure, Circulation, 77, 721, 10.1161/01.CIR.77.4.721 Cody, 1994, Plasma endothelin correlates with extent of pulmonary hypertension in patients with chronic heart failure, Circulation, 85, 504, 10.1161/01.CIR.85.2.504 Tsutamoto, 1994, Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure, J Am Coll Cardiol, 23, 1427, 10.1016/0735-1097(94)90387-5 Swedberg, 1990, Hormones regulating cardiovascular function in patients with severe congestive heart failure and relation to mortality, Circulation, 82, 1730, 10.1161/01.CIR.82.5.1730 Rouleau, 1994, Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril, J Am Coll Cardiol, 24, 583, 10.1016/0735-1097(94)90001-9 Tsutamoto, 1995, Prognostic value of plasma intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure, Am J Cardiol, 76, 803, 10.1016/S0002-9149(99)80231-8 Gottlieb, 1989, Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure, J Am Coll Cardiol, 13, 1534, 10.1016/0735-1097(89)90344-6 Benedict, 1995, Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction, Am J Cardiol, 75, 1151, 10.1016/S0002-9149(99)80748-6 Yoshimura, 1993, Different secretion pattern of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure, Circulation, 87, 464, 10.1161/01.CIR.87.2.464 Morita, 1993, Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction, Circulation, 88, 82, 10.1161/01.CIR.88.1.82 Motwami, 1993, Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction, Lancet, 34, 1109, 10.1016/0140-6736(93)93126-L Yasue, 1994, Localization and mechanism of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure, Circulation, 90, 195, 10.1161/01.CIR.90.1.195 Bates, 1986, The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man, Circulation, 73, 1155, 10.1161/01.CIR.73.6.1155 Rodeheffer, 1986, Atrial pressure and secretion of atrial natriuretic factor into the human central circulation, J Am Coll Cardiol, 8, 18, 10.1016/S0735-1097(86)80086-9 Raine, 1986, Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure, N Engl J Med, 315, 533, 10.1056/NEJM198608283150901 Tsutamoto, 1989, Plasma atrial natriuretic polypeptide as an index of left ventricular end-diastolic pressure in patients with chronic left-sided heart failure, Am Heart J, 117, 599, 10.1016/0002-8703(89)90734-5 Tsutamoto, 1997, Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction, Circulation, 96, 509, 10.1161/01.CIR.96.2.509 Levine, 1982, Activity of the sympathetic nervous system and renin-angiotensin assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure, Am J Cardiol, 49, 1659, 10.1016/0002-9149(82)90243-0 Suzuki, 1992, Cellular mechanisms for synthesis and secretion of atrial natriuretic peptide and brain natriuretic peptide in cultured rat atrial cells, Circ Res, 71, 1039, 10.1161/01.RES.71.5.1039 Horio, 1993, Cosecretion of atrial and brain natriuretic peptides stimulated by endothelin-1 from cultured rat atrial and ventricular cardiocytes, Metabolism, 42, 94, 10.1016/0026-0495(93)90178-Q Rona, 1985, Catecholamine cardiotoxicity, J Mol Cell Cardiol, 17, 291, 10.1016/S0022-2828(85)80130-9 Downing, 1983, Contribution alpha-adrenoceptor activation to the pathogenesis of norepinephrine cardiomyopathy, Circ Res, 52, 471, 10.1161/01.RES.52.4.471 Lee, 1985, Role of alpha1-adrenoceptors in norepinephrine-induced cardiomyopathy, Am J Pathol, 121, 316 Sakai, 1996, Inhibition of myocardial endothelin pathway improves long-term survival in heart failure, Nature, 384, 353, 10.1038/384353a0 Burnett, 1986, Atrial natriuretic peptide elevation in congestive heart failure in the human, Science, 231, 1145, 10.1126/science.2935937 Nakagawa, 1995, Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy, J Clin Invest, 96, 1280, 10.1172/JCI118162 Ogawa, 1991, Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats, Circ Res, 69, 491, 10.1161/01.RES.69.2.491 Hama, 1995, Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction, Circulation, 92, 1558, 10.1161/01.CIR.92.6.1558 Omland, 1996, Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide, Circulation, 93, 1963, 10.1161/01.CIR.93.11.1963